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Hereditary angioedema (HAE) is a rare autosomal 
dominant disease (1:50 000 individuals) [1]. The most common 
forms of HAE result from mutations in the C1 esterase inhibitor 
(C1-INH) gene (SERPING1) that lead to a quantitative or 
qualitative C1-INH deficiency. The 3 types of C1-INH that 
have been described to date are as follows: C1-INH-HAE 
type 1, which is characterized by C1-INH quantitative 
deficiency; C1-INH-HAE type 2, which is characterized by 
C1-INH qualitative deficiency; and nl-C1-INH-HAE, which 
is characterized by normal C1-INH levels and function and 
is due to a heterogeneous gene mutation that includes FXII-
HAE (F12 gene), ANGPT1-HAE (angiopoietin 1), PLG-HAE 
(plasminogen), KNG1-HAE (kininogen 1), and UNK-HAE 
(unknown) [1]. Clinically, HAE is characterized by recurrent, 
nonpruritic edema, which typically involves subcutaneous 
tissue (face, extremities) and mucosal tissue (oropharyngeal, 
laryngeal, and gastrointestinal) and may last up to 3-5 days 
without treatment [1]. Involvement of the upper airways 
and gastrointestinal system can lead to airway obstruction, 
asphyxia, and abdominal attack [1,2]. Early diagnosis is 
therefore fundamental. 
Abdominal attack is characterized by abdominal pain with 
or without other symptoms such as nausea, vomiting, diarrhea, 
and abdominal distension. These symptoms are secondary to 
transient edema of the wall of the intestinal tract and fluid shifts 
into the intestinal lumen or the peritoneal cavity [2]. In rare 
cases, abdominal attack manifests with signs of pancreatitis. 
Our aim was to increase physicians’ awareness of pancreatitis 
as a sign or complication of abdominal attack in HAE. We 
report a case of acute pancreatitis due to abdominal attack 
of HAE with exclusively pancreatic edema and elevation of 
pancreatic enzymes in which C1-INH therapy was essential 
for clinical resolution. A 39-year-old woman with type 2 C1-
INH-HAE and a history of multiple episodes of angioedema of 
the extremities since age 16 years was seen in our Outpatient 
Department at age 25 years. Her laboratory values were as 
follows: C3, 140 mg/dL (90-180); C4, 3 mg/dL (10-40); C1-INH, 
56 mg/dL (18-32); and functional C1-INH, 30% (>68). She 
was initially treated with aminocaproic acid, which partially 
controlled the angioedema. At age 35 years, she presented 
with several episodes of abdominal pain and vomiting and 
started treatment with stanozolol 2 mg/d, which improved 
her symptoms. At age 39 years, under irregular treatment 
with stanozolol, she went to the Emergency Department 
with a new episode of intense and colicky epigastric pain 
in association with nausea and vomiting. She has no history 
of alcohol consumption or trauma and was not taking other 
medications. Abdominal ultrasound revealed a globular and 
swollen pancreas, with a heterogeneous and hypoechoic 
structure. There were no other relevant findings, including 
no free intraperitoneal fluid. C-reactive protein (CRP) had 
increased by 17.3 mg/dL and pancreatic enzyme values 
were elevated (lipase, 512 U/L; amylase, 374 U/L). No other 
analytical changes were recorded (leukocytes, hematocrit, 
bilirubin, and transaminases). The patient was treated with 
several analgesics (acetaminophen, butylscopolamine, and 
tramadol), although her symptoms did not improve. HAE 
was accepted as being the cause of the acute pancreatitis and, 
8 hours after the onset of abdominal attack, 1000 U of C1-
INH concentrate (Berinert, CSL Behring) was administered; 
her symptoms resolved within about 30 minutes. She was 
hospitalized for observation without the need for analgesics. 
After 24 hours, a second abdominal ultrasound scan did not 
reveal pancreatic changes but did reveal the presence of a 
moderate amount of free fluid in the Morrison space and in the 
pouch of Douglas that were not evident in the first scan. CRP 
and pancreatic enzyme levels had decreased. The patient was 
discharged 96 hours later; she was asymptomatic and had been 
diagnosed with abdominal attack of HAE with exclusively 
pancreatic involvement.
Gastrointestinal tract involvement is one of the most 
common features of HAE, and attacks affecting the abdomen 
are almost as common as those affecting the skin (>90% of 
patients) [3]. The difficulty in associating gastrointestinal 
symptoms with an abdominal attack of HAE often leads to an 
incorrect diagnosis, such as irritable bowel syndrome or renal 
colic. Appendicitis, intestinal obstruction, and cholecystitis 
may be suspected and consequently lead to unnecessary 
surgical procedures. One study concluded that one third 
of HAE patients with abdominal symptoms underwent 
unnecessary abdominal surgeries [2]. In rare cases, abdominal 
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attacks of HAE are associated with acute pancreatitis. Although 
this association is not fully documented, it is thought that 
pancreatic edema may cause obstruction of the pancreatic duct 
or the ampulla of Vater, leading to episodes of pancreatitis [3]. 
The Table shows several published cases [3-8] of acute 
pancreatitis due to abdominal attack of HAE. All patients were 
treated with specific HAE therapy, and symptoms improved. 
This improvement was faster in patients undergoing treatment 
of an acute attack.
The unspecific symptoms of abdominal attack of 
HAE can hamper diagnosis and, in the absence of clinical 
suspicion, treatment may be postponed altogether. In addition, 
laboratory parameters remain largely unchanged, except for 
an increase in hematocrit, which is probably secondary to 
hemoconcentration, dehydration, and translocation of fluid 
into the intestinal wall, as well as leukocytosis [9]. A recent 
study [10] found a correlation between CRP levels and 
abdominal attack of HAE: increased CRP levels during the 
attack are found mainly in patients with abdominal locations. 
In the absence of an attack, increased CRP levels may alert 
the physician to severe inflammation. Imaging may prove 
useful in the initial investigation of abdominal pain episodes. 
During an abdominal attack, endoscopy may show ascites 
and/or visceral edema and frequently edema of the intestinal 
wall [2]. Since intestinal swelling associated with acute HAE 
attacks could induce pancreatitis, serum amylase and lipase 
should be monitored, as management of the attack could vary 
depending on the results.
The therapies currently available for treatment of HAE 
attacks comprise C1-INH concentrate, hr-C1-INH, icatibant, 
and ecallantide [1]. As no specific biomarker of this condition 
has been identified, rapid improvement in symptoms after 
administration of specific therapy enables us to differentiate 
between abdominal attacks of HAE and other etiologies.
Although rare, HAE is associated with significant 
comorbidity, and a history of unnecessary abdominal 
surgeries is not unusual in abdominal attack of HAE. Health 
professionals should be aware of the existence of this entity 
to perform early diagnosis and institute appropriate therapy. 
Since HAE is a potential cause of acute abdomen (eg, acute 
pancreatitis), HAE-specific therapy should be considered a 
therapeutic option.
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Paper Gender, Lipase, Amylase, Treatment Clinical Gastrointestinal 
 Age U/L U/L  Evaluation Surgeries
Our case F, 39 512 374 C1 inhibitor Improvement in 30 min  No history
Lopez-Veronez et al [3] M, 21 1.159 292 Icatibant Improvement in 3 h No history 
 F, 47 ND 210 Icatibant Improvement in 1 h Appendectomy
Loudin et al [4] F, 56 663 ND C1 inhibitor Improvement in 30 min Cholecystectomy
Maamer et al [5] F, 73 1235 869 Danazol Improvement in 5 d   No history 
Czaller et al  [6] F, 29 1452 2615 C1 inhibitor (2 times) Improvement in 4 h   Appendectomy
Cancian et al [7] F, 32 ND 470 C1 inhibitor Improvement in 30 min  ND
Abbreviations: F, female; M, male; ND, not determined.
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Members of the Rosaceae family are the most frequent 
cause of allergic reactions to fruits in the Mediterranean 
area [1]. Strawberry, which belongs to the Rosoideae subfamily 
of Rosaceae, has an apparently unjustified poor reputation 
among the general population, as self-reported symptoms after 
ingestion of strawberry are very common [2,3]. However, few 
cases of true allergy have been reported in the literature [4-7].
The aim of our study was to make a descriptive analysis 
of pediatric patients with a history of self-reported strawberry 
allergy and to investigate whether they had true allergy. 
Patients from the Pediatric Allergy Department of Hospital 
General Universitario Gregorio Marañón, Madrid, Spain were 
retrospectively analyzed on the basis of a clinical history of 
strawberry allergy, specific IgE (sIgE) to strawberry, and age 
under 17 years. 
The data we recorded included demographic and clinical 
characteristics, specific IgE (sIgE) values to strawberry 
(ImmunoCAP 250, Thermo Fisher Scientific), skin prick test 
(SPT) results with a commercial strawberry extract (Leti), 
sensitization to profilin by prick and peach nonspecific lipid 
transfer protein (nsLTP) by prick (peach extract enriched with 
Pru p 3 [ALK-Abelló] or Pru p 3 [ImmunoCAP ]), and tolerance 
to strawberry in oral food challenge (OFC). sIgE values to birch 
PR-10 (Bet v 1) were not analyzed, as sensitization to birch 
pollen is not common in our area. SPT wheals ≥3 mm and sIgE 
values ≥0.35 kU/L were considered positive.
Qualitative variables are expressed as a frequency 
and quantitative variables as median (IQR). Categorical 
variables were compared using the 2 test and Fisher exact 
test; quantitative variables were compared using the Mann-
Whitney test.
The study population comprised 43 children with a clinical 
history of strawberry allergy. Of these, 29 (67%) had a positive 
SPT and/or sIgE result to strawberry (group 1) and 14 (33%) 
had negative results in both tests (group 2). 
Median time between self-reported symptoms related to 
strawberry intake and the allergological work-up was 4 (3-6) 
months; median time from symptoms to the assessment of 
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